Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse

Clinical trial NCT00248092 · COMPLETED

Trial details

NCT number: NCT00248092
Sponsor: New River Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Attention Deficit Disorder With Hyperactivity Amphetamine-Related Disorders Substance-Related Disorders

Start date: 2006-01-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.